Status:

UNKNOWN

The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study

Lead Sponsor:

XDx

Conditions:

Systemic Lupus Erythematosus

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this study is to enable the study sponsor to develop a new blood test method for clinicians to accurately predict which individuals with lupus will flare, when the flare will occur, and fl...

Detailed Description

This study is currently enrolling individuals who have an established diagnosis of SLE to participate. There is no cost to volunteers who participate and the study pays for the visits to the clinics f...

Eligibility Criteria

Inclusion

  • Individual has met the diagnostic criteria for SLE (at least 4 out of the 11) American College of Rheumatology (ACR) criteria and:
  • Has experienced specific manifestations of lupus disease activity within the last 12 months including the following:
  • Lupus nephritis (kidney disease); vasculitis and or central nervous system involvement and/or:
  • Required treatment with at least 20 mg per day of prednisone (or equivalent) and/or:
  • Required hospitalization directly due to SLE disease

Exclusion

  • Subjects unable or unlikely to cooperate with the procedures of the protocol
  • Substance abuse / dependence that in the opinion of the investigator could compromise the subject's ability to complete the study
  • Subject with a more dominant autoimmune disease, e.g. Rheumatoid arthritis, Sjogren's syndrome, multiple sclerosis, scleroderma
  • History of malignancy within the last five years with the exception of basal cell carcinoma
  • Active infection: Known HIV positive status, currently active tuberculosis , active infection receiving antibiotics
  • Had tissue or organ transplantation (including bone marrow)
  • On chronic hemo- or peritoneal dialysis

Key Trial Info

Start Date :

December 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2010

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT00671047

Start Date

December 1 2007

End Date

June 1 2010

Last Update

December 31 2008

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

2

East Bay Rheumatology Medical Group

San Leandro, California, United States, 94578

3

Emory University

Atlanta, Georgia, United States, 30303

4

Kansas University Medical Center

Kansas City, Kansas, United States, 66160